Effect of cholecalciferol supplementation on hand grip strength, walking speed, and expression of vitamin D receptor, interleukin-6, and insulin-like growth factor-1 in monocyte in pre-frail older adults: A randomized double-blind placebo-controlled trial.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Japan Geriatrics Society Country of Publication: Japan NLM ID: 101135738 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1447-0594 (Electronic) Linking ISSN: 14470594 NLM ISO Abbreviation: Geriatr Gerontol Int Subsets: MEDLINE
    • Publication Information:
      Original Publication: [Tokyo, Japan] : Carlton, Vic., Australia : Japan Geriatrics Society ; Blackwell Science, c2001-
    • Subject Terms:
    • Abstract:
      Aim: To investigate the effect of cholecalciferol supplementation on hand grip strength, walking speed, and expression of vitamin D receptor (VDR), interleukine-6 (IL-6) and insulin-like growth factor-1 (IGF-1) in monocyte in pre-frail older adults.
      Methods: We conducted a randomized double-blinded placebo-controlled clinical trial for 12 weeks, involving 120 pre-frail older adults who were randomized to the cholecalciferol group (cholecalciferol 4000 IU/day) or the placebo group. All subjects were given calcium lactate 500 mg/day. Hand grip strength and walking speed, as primary outcomes, were analyzed using intention-to-treat analysis. The expression of VDR, IGF-1 and IL-6 in monocytes, as secondary outcomes, were analyzed using per-protocol analysis.
      Results: After a 12-week intervention, there was a significant increase in serum 25(OH)D levels in both groups, with the increase being higher in the cholecalciferol group than in the placebo group (49.05 vs. 24.01 ng/mL; P < 0.001). No statistically significant differences were observed in hand grip strength (P = 0.228) and walking speed (P = 0.734) between the groups. There were no differences in the expression of VDR (P = 0.513), IL-6 (P = 0.509), and IGF-1 (P = 0.503) monocytes between the groups.
      Conclusions: Cholecalciferol supplementation for 12 weeks increased serum 25(OH)D levels among pre-frail older adults. However, it did not improve hand grip strength and walking speed, and nor did it change the expression of VDR, IL-6, and IGF-1 in monocytes. Geriatr Gerontol Int 2024; 24: 554-562.
      (© 2024 Japan Geriatrics Society.)
    • Comments:
      Erratum in: Geriatr Gerontol Int. 2024 Aug 21. doi: 10.1111/ggi.14960. (PMID: 39166366)
    • References:
      Fried LP, Tangen CM, Walston J et al. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56: M146–M156.
      Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet 2019; 394: 1365–1375.
      Chen X, Mao G, Leng SX. Frailty syndrome: an overview. Clin Interv Aging 2014; 9: 433–441.
      Wesson DE, Mathur V, Tangri N. Metabolic basis and pathogenesis of skeletal muscle dysfunction as cause of frailty in chronic kidney disease. Am J Nephrol 2022; 53: 740–752.
      Costamagna D, Costelli P, Sampaolesi M, Penna F. Role of inflammation in muscle homeostasis and myogenesis. Mediators Inflamm 2015; 2015: 805172.
      Tuttle CSL, Thang LAN, Maier AB. Markers of inflammation and their association with muscle strength and mass: a systematic review and meta‐analysis. Ageing Res Rev 2020; 64: 101185.
      Bano G, Trevisan C, Carraro S et al. Inflammation and sarcopenia: a systematic review and meta‐analysis. Maturitas 2017; 96: 10–15.
      Baylis D, Bartlett DB, Patel HP, Roberts HC. Understanding how we age: insights into inflammaging. Longev Healthspan 2013; 2: 8.
      Hearps AC, Martin GE, Angelovich TA et al. Aging is associated with chronic innate immune activation and dysregulation of monocyte phenotype and function. Aging Cell 2012; 11: 867–875.
      Novak ML, Koh TJ. Phenotypic transitions of macrophages orchestrate tissue repair. Am J Pathol 2013; 183: 1352–1363.
      Arnold L, Henry A, Poron F et al. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J Exp Med 2007; 204: 1057–1069.
      Tidball JG, Welc SS. Macrophage‐derived IGF‐1 is a potent coordinator of myogenesis and inflammation in regenerating muscle. Mol Ther 2015; 23: 1134–1135.
      Dumont N, Frenette J. Macrophages protect against muscle atrophy and promote muscle recovery in vivo and in vitro: a mechanism partly dependent on the insulin‐like growth factor‐1 signaling molecule. Am J Pathol 2010; 176: 2228–2235.
      Goncalves de Carvalho CM, Ribeiro SM. Aging, low‐grade systemic inflammation and vitamin D: a mini‐review. Eur J Clin Nutr 2017; 71: 434–440.
      Cohen‐Lahav M, Shany S, Tobvin D, Chaimovitz C, Douvdevani A. Vitamin D decreases NFkappa B activity by increasing IkappaBalpha levels. Nephrol Dial Transplant 2006; 21: 889–897.
      Pike JW, Meyer MB. The vitamin D receptor: new paradigms for the regulation of gene expression by 1,25‐dihydroxyvitamin D3. Endocrinol Metab Clin North Am 2010; 39: 255–269.
      Calton EK, Keane KN, Newsholme P, Soares MJ. The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS One 2015; 10: e0141770.
      Dalle S, Rossmeislova L, Koppo K. The role of inflammation in age‐related sarcopenia. Front Physiol 2017; 8: 1045.
      de Souza WN, Martini LA. The role of vitamin D in obesity and inflammation at adipose tissue. J Obes Metab Res 2015; 2: 161–166.
      Dzik KP, Kaczor JJ. Mechanisms of vitamin D on skeletal muscle function: oxidative stress, energy metabolism and anabolic state. Eur J Appl Physiol 2019; 119: 825–839.
      Beaudart C, Buckinx F, Rabenda V et al. The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta‐analysis of randomized controlled trials. J Clin Endocrinol Metab 2014; 99: 4336–4345.
      Muir SW, Montero‐Odasso M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta‐analysis. J Am Geriatr Soc 2011; 59: 2291–2300.
      Rosendahl‐Riise H, Spielau U, Ranhoff AH, Gudbrandsen OA, Dierkes J. Vitamin D supplementation and its influence on muscle strength and mobility in community‐dwelling older persons: a systematic review and meta‐analysis. J Hum Nutr Diet 2017; 30: 3–15.
      Abshirini M, Mozaffari H, Kord‐Varkaneh H, Omidian M, Kruger MC. The effects of vitamin D supplementation on muscle strength and mobility in postmenopausal women: a systematic review and meta‐analysis of randomised controlled trials. J Hum Nutr Diet 2020; 33: 207–221.
      Tabrizi R, Hallajzadeh J, Mirhosseini N et al. The effects of vitamin D supplementation on muscle function among postmenopausal women: a systematic review and meta‐analysis of randomized controlled trials. EXCLI J 2019; 18: 591–603.
      Setiati S, Laksmi PW, Aryana I et al. Frailty state among Indonesian elderly: prevalence, associated factors, and frailty state transition. BMC Geriatr 2019; 19: 182.
      Siriwardhana DD, Hardoon S, Rait G, Weerasinghe MC, Walters KR. Prevalence of frailty and prefrailty among community‐dwelling older adults in low‐income and middle‐income countries: a systematic review and meta‐analysis. BMJ Open 2018; 8: e018195.
      American Geriatrics Society Workgroup on Vitamin D Supplementation for Older Adults. Recommendations abstracted from the American Geriatrics Society consensus statement on vitamin D for prevention of falls and their consequences. J Am Geriatr Soc 2014; 62: 147–152.
      Ross AC, Manson JE, Abrams SA et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96: 53–58.
      Kenny AM, Biskup B, Robbins B, Marcella G, Burleson JA. Effects of vitamin D supplementation on strength, physical function, and health perception in older, community‐dwelling men. J Am Geriatr Soc 2003; 51: 1762–1767.
      Janssen HC, Samson MM, Verhaar HJ. Muscle strength and mobility in vitamin D‐insufficient female geriatric patients: a randomized controlled trial on vitamin D and calcium supplementation. Aging Clin Exp Res 2010; 22: 78–84.
      Latham NK, Anderson CS, Lee A et al. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the frailty interventions trial in elderly subjects (FITNESS). J Am Geriatr Soc 2003; 51: 291–299.
      Smedshaug G, Pedersen J, Meyer H. Can vitamin D supplementation improve grip strength in elderly nursing home residents? A double‐blinded controlled trial. Scand J Food Nutr 2007; 51: 74–78.
      Pirotta S, Kidgell DJ, Daly RM. Effects of vitamin D supplementation on neuroplasticity in older adults: a double‐blinded, placebo‐controlled randomised trial. Osteoporos Int 2015; 26: 131–140.
      Vaes AMM, Tieland M, Toussaint N et al. Cholecalciferol or 25‐hydroxycholecalciferol supplementation does not affect muscle strength and physical performance in prefrail and frail older adults. J Nutr 2018; 148: 712–720.
      Bray NW, Doherty TJ, Montero‐Odasso M. The effect of high dose vitamin D3 on physical performance in frail older adults. A feasibility study. J Frailty Aging 2018; 7: 155–161.
      Rizka A, Setiati S, Harimurti K, Sadikin M, Mansur IG. Effect of alfacalcidol on inflammatory markers and T cell subsets in elderly with frailty syndrome: a double blind randomized controlled trial. Acta Med Indones 2018; 50: 215–221.
      Setiati S, Anugrahini FJE, Tamin TZ, Istanti R. Combination of alfacalcidol and calcium improved handgrip strength and mobility among Indonesian older women: a randomized controlled trial. Geriatr Gerontol Int 2018; 18: 434–440.
      Vellas B, Guigoz Y, Garry PJ et al. The mini nutritional assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999; 15: 116–122.
      Hanwell HE, Vieth R, Cole DE et al. Sun exposure questionnaire predicts circulating 25‐hydroxyvitamin D concentrations in Caucasian hospital workers in southern Italy. J Steroid Biochem Mol Biol 2010; 121: 334–337.
      Laksmi PW, Setiati S, Tamin TZ et al. Effect of metformin on handgrip strength, gait speed, myostatin serum level, and health‐related quality of life: a double blind randomized controlled trial among non‐diabetic pre‐frail elderly patients. Acta Med Indones 2017; 49: 118–127.
      Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: a systematic review and meta‐analysis. Osteoporos Int 2011; 22: 859–871.
      Bislev LS, Grove‐Laugesen D, Rejnmark L. Vitamin D and muscle health: a systematic review and meta‐analysis of randomized placebo‐controlled trials. J Bone Miner Res 2021; 36: 1651–1660.
      Prokopidis K, Giannos P, Katsikas Triantafyllidis K et al. Effect of vitamin D monotherapy on indices of sarcopenia in community‐dwelling older adults: a systematic review and meta‐analysis. J Cachexia Sarcopenia Muscle 2022; 13: 1642–1652.
      Grant WB, Karras SN, Bischoff‐Ferrari HA et al. Do studies reporting ‘U’‐shaped serum 25‐hydroxyvitamin D‐health outcome relationships reflect adverse effects? Dermatoendocrinol 2016; 8: e1187349.
      Smith LM, Gallagher JC, Suiter C. Medium doses of daily vitamin D decrease falls and higher doses of daily vitamin D3 increase falls: a randomized clinical trial. J Steroid Biochem Mol Biol 2017; 173: 317–322.
      Castle M, Fiedler N, Pop LC et al. Three doses of vitamin D and cognitive outcomes in older women: a double‐blind randomized controlled trial. J Gerontol A Biol Sci Med Sci 2020; 75: 835–842.
      Direktorat Jenderal Kesehatan Masyarakat. Panduan Pelayanan Kesehatan Lanjut Usia Pada Era Pandemi Covid‐19. Jakarta: Kementerian Kesehatan Republik Indonesia, 2020.
      Zittermann A, Berthold HK, Pilz S. The effect of vitamin D on fibroblast growth factor 23: a systematic review and meta‐analysis of randomized controlled trials. Eur J Clin Nutr 2021; 75: 980–987.
      Kim CS, Kim SW. Vitamin D and chronic kidney disease. Korean J Intern Med 2014; 29: 416–427.
      Zittermann A, Ernst JB, Birschmann I, Dittrich M. Effect of vitamin D or activated vitamin D on circulating 1,25‐dihydroxyvitamin D concentrations: a systematic review and Metaanalysis of randomized controlled trials. Clin Chem 2015; 61: 1484–1494.
      Krasniqi E, Boshnjaku A, Wagner KH, Wessner B. Association between polymorphisms in vitamin D pathway‐related genes, vitamin D status, muscle mass and function: a systematic review. Nutrients 2021; 13(9): 3109. doi:10.3390/nu1309310.
      Harimurti K, Setiati S, Soejono CH et al. Sarcopenia in a multiethnic state: a cross‐sectional data analysis of multicentre Indonesia longitudinal aging study. Acta Med Indones 2023; 55: 61–69.
      Carlberg C, Haq A. The concept of the personal vitamin D response index. J Steroid Biochem Mol Biol 2018; 175: 12–17.
      Zhang Y, Leung DY, Richers BN et al. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase‐1. J Immunol 2012; 188: 2127–2135.
      Saccone D, Asani F, Bornman L. Regulation of the vitamin D receptor gene by environment, genetics and epigenetics. Gene 2015; 561: 171–180.
      Usategui‐Martin R, De Luis‐Roman DA, Fernandez‐Gomez JM, Ruiz‐Mambrilla M, Perez‐Castrillon JL. Vitamin D receptor (VDR) gene polymorphisms modify the response to vitamin D supplementation: a systematic review and meta‐analysis. Nutrients 2022; 14: 360.
    • Grant Information:
      NKB-1255/UN2.RST/HKP.05.00/2022 Direktorat Riset and Pengembangan, Universitas Indonesia Hibah Publikasi Terindeks International (PUTI) 2022
    • Contributed Indexing:
      Keywords: cholecalciferol; hand grip strength; monocytes; pre‐frail older adult; walking speed
    • Accession Number:
      0 (Interleukin-6)
      1C6V77QF41 (Cholecalciferol)
      0 (Receptors, Calcitriol)
      67763-96-6 (Insulin-Like Growth Factor I)
      1406-16-2 (Vitamin D)
      0 (IL6 protein, human)
      0 (Vitamins)
      0 (Insulin-Like Peptides)
    • Publication Date:
      Date Created: 20240422 Date Completed: 20240602 Latest Revision: 20240821
    • Publication Date:
      20240821
    • Accession Number:
      10.1111/ggi.14881
    • Accession Number:
      38644647